Exchange Traded Concepts’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Buy |
5,914
+112
| +2% | +$11.9K | 0.01% | 848 |
|
|
2025
Q1 | $720K | Sell |
5,802
-1,243
| -18% | -$154K | 0.01% | 708 |
|
|
2024
Q4 | $868K | Buy |
7,045
+155
| +2% | +$19.1K | 0.02% | 615 |
|
|
2024
Q3 | $768K | Buy |
6,890
+1,233
| +22% | +$137K | 0.02% | 637 |
|
|
2024
Q2 | $604K | Buy |
5,657
+283
| +5% | +$30.2K | 0.02% | 644 |
|
|
2024
Q1 | $647K | Buy |
5,374
+770
| +17% | +$92.7K | 0.02% | 572 |
|
|
2023
Q4 | $566K | Hold |
4,604
| – | – | 0.02% | 585 |
|
|
2023
Q3 | $596K | Buy |
4,604
+284
| +7% | +$36.8K | 0.02% | 523 |
|
|
2023
Q2 | $536K | Buy |
4,320
+70
| +2% | +$8.68K | 0.01% | 595 |
|
|
2023
Q1 | $622K | Sell |
4,250
-826
| -16% | -$121K | 0.02% | 481 |
|
|
2022
Q4 | $809K | Buy |
5,076
+286
| +6% | +$45.6K | 0.02% | 334 |
|
|
2022
Q3 | $638K | Buy |
4,790
+4
| +0.1% | +$533 | 0.02% | 344 |
|
|
2022
Q2 | $747K | Buy |
4,786
+402
| +9% | +$62.7K | 0.02% | 338 |
|
|
2022
Q1 | $682K | Buy |
4,384
+399
| +10% | +$62.1K | 0.01% | 420 |
|
|
2021
Q4 | $508K | Sell |
3,985
-233
| -6% | -$29.7K | 0.01% | 676 |
|
|
2021
Q3 | $549K | Buy |
4,218
+917
| +28% | +$119K | 0.01% | 508 |
|
|
2021
Q2 | $586K | Buy |
3,301
+129
| +4% | +$22.9K | 0.02% | 468 |
|
|
2021
Q1 | $521K | Buy |
3,172
+2,962
| +1,410% | +$487K | 0.02% | 448 |
|
|
2020
Q4 | $35K | Buy |
+210
| New | +$35K | ﹤0.01% | 775 |
|